John Scott, M.D., Ph.D.

Assistant Professor

Director, Clinical Microbiology and Clinical Chemistry and Director, TMC Laboaratory and POC
John Scott, MD, PhD

Education & Affiliations

1979 – 1985 M.D., University of L'Aquila, School of Medicine, L'Aquila, Italy
1969 – 1974 Ph.D., Microbiology and Immunology, University of Oregon School of Medicine, Portland, OR
1968 – 1969 M.A., Biology, Pacific Union College Angwin, CA
1962 – 1968 B.S., Biology, Pacific Union College Angwin, CA
2006-2008 Fellowship, Transfusion Medicine, The Methodist Hospital, Department of Pathology, Houston TX
2007-2008 Fellowship, Hematopathology, Tulane University Medical School, New Orleans, LA
2003-2006, Residency, Clinical Pathology, Tulane University Medical School, New Orleans, LA
1974-1976, Postdoctoral Fellow, Clinical Microbiology, University of Washington, Seattle, WA
1989-1991 Fellowship, Rheumatology, Oregon Health Sciences University, Portland, OR
1985-1988, Internship/Residency, Internal Medicine, St. Joseph's Hospital, Paterson, NJ

Biography

Certification:

Board Certified in Clinical Pathology and Transfusion

Faculty Appointments:

1995-2003  Assistant Professor and Acting Chief: Rheumatology
Tulane University Medical School, New Orleans, LA

2001-2003  Associate Dean:  Information Technology
Tulane University Medical School, Office of Information Technology, New Orleans, LA

1974-1978  Assistant Professor, Department of Microbiology and Immunology
Loma Linda University School of Medicine, Loma Linda, CA   

Clinical and Teaching Responsibilities

Medical Director: Clinical Chemistry, Microbiology and Laboratory Information Systems (LIS)
Associate Director Blood Bank and Apheresis

Contributions

Original Manuscripts, Letters and Commentaries:

1.    Bruce E. Bowdish, Sheila W. Chauvin, Norman Kreisman, JOHN W. SCOTT, Mike Britt: Virtual Problem-Based Learning (VPBL): Design experimentation for curricular deployment.  Instructional Science Special Edition Winter 2003 Issue 1.

2.    Alan Miller Ph.D. M.D., JOHN W. SCOTT Ph.D. M.D.:  Stem Cell Transplantation for the Treatment of Refractory Lupus Nephritis.  Show Chwan Medical Journal 2001.

3.    Wooten, MD, SCOTT, JW, Miller, AM and Boh, E.:  Chronic Myelogenous Leukemia and Porphyria Cutanea Tarda in a Patient with Limited Systemic Sclerosis.   Southern Medical Journal Vol. 91, No. 5, May 1998.

4.    Miller, A., Batuman and SCOTT, J.:  Treatment of Refractory Lupus Nephritis with Stem Cell Transplantation.  Southern Medical Journal Submitted October 8, 1998.

5.    Miller, AM, Wooten, MD, SCOTT, JW, Boh, E and Rink, J.:  Regression of scleroderma following an allogeneic bone marrow transplant for chronic myelogenous leukemia.  Tulane University Medical Center, Departments of Medicine and Dermatology, New Orleans, LA., Accepted for Publication.

Abstracts:  

1.  R  Davey and J SCOTT:  Probability of Anti-D Antibody Development Among Rh negative Hospitalized Patients Receiving Rh Positive Packed Red Blood Cells, AABB Meetings 2007.

2.  JOHN W. SCOTT, M.D., Alona Franciois, Tayler Hynh-Le Pharm D.:  Experience with Remicade (Infliximab) in the Treatment of Mixed Connective Tissue Disease/Lupus.  EULAR July 2002.

3.  JOHN W. SCOTT, M.D., Tayler Huynh Le, Pharm.D, Jeanette H. Magnus, M.D.:  Remicade (Infliximab) in patients with Systemic Lupus Erythematosus and Leukopenia.  American Academy of Rheumatology Oct 2002.

4.  JW SCOTT:  Effective Treatment of Systemic Lupus Erythematosus with high Dose Cyclophosphamide Followed by G-CSF.  Southern Regional Meetings 1999.

5.  SCOTT, JW, Elwell, L and Falkow, S:  Plasmid independent penicillin resistance and Beta-lactamase activity in Bacteroides fragilis.   American Society for Microbiology Northwest Branch Meeting, 1976.

Sickle Cell Disease
Web-Based Medical Education
Natural Language Processing